Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Labelled, Multicenter Phase II Study of Rituximab in Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease

NCT00472225 is registered in ClinicalTrials.gov with The Korean Society of Hematopoietic Stem Cell Transplantation as lead sponsor.

NCT NCT00472225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00472225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Labelled, Multicenter Phase II Study of Rituximab in Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease
Lead sponsor
The Korean Society of Hematopoietic Stem Cell Transplantation
Phase
Phase 2
Overall status
Unknown status
Start date
May 31, 2007
Completion date
May 31, 2009
Enrollment
42 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

steroid-refractory chronic gvhd